It is well established that RANKL is a key cytokine affecting the immune system, including T cells, B cells, and macrophages (14–16), and it has been reported that RSPO signaling promotes macrophage polarization in the tumor microenvironment (17). Here, RSPO1 is linked to neoplasm.